Exhibit 99.1
Functional Brands Announces Third Quarter 2025 Financial Results
Lake Oswego, OR – (December 15, 2025) – Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 highlights:
| ● | Revenue of $1.7 million increased 21.4% compared to the third quarter of 2024, primarily due to growth in direct-to-consumer sales | |
| ● | Gross profit increased 28.1% compared to the prior year period and gross profit margin improved 310 basis points to 57.8% reflecting higher revenue, improved cost control and better terms with vendors | |
| ● | Net income of $0.3 million or $0.04 per diluted share compared to a net loss of $0.3 million and $(0.04) per diluted share in the prior year period |
“We are pleased with our third quarter results as we delivered strong growth on the top and bottom line, reflecting early progress on our key initiatives,” said Eric Gripentrog, CEO of Functional Brands Inc. “The past few months have been transformational for Functional Brands, marked by several milestone achievements that position us strongly for accelerated growth. Most notably, we successfully completed our direct listing on the Nasdaq Capital Market under the symbol MEHA, representing a pivotal moment that validates our business model and provides the capital foundation to execute our ambitious expansion plans.
“We also achieved significant strategic breakthroughs that differentiate us in the marketplace. Our P2i by Kirkman prenatal supplement has become the world’s first to fully align with FIGO’s transparency standards and the first to comply with California’s new SB 646 QR-code disclosure law—well ahead of the January 2027 implementation date. Additionally, we forged a high-impact commercial partnership with Market Performance Group to supercharge the growth of our flagship Kirkman brand across eCommerce and digital channels, unlocking new opportunities to reach millions of consumers with our science-based wellness solutions. These accomplishments demonstrate that we are executing on our mission of ‘Making Everyone Healthy Again’ while building a foundation for sustainable, profitable growth.”
About Functional Brands Inc.
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Hemptown Naturals, Healthy Assist by Kirkman; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives.
For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com.
Investor Relations Contact:
FunctionalBrands@icrinc.com
Cautionary Note Regarding Forward Looking Statements
This news release and statements of Functional Brands’ management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “potential,” “will,” “should,” “could,” “would,” “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.
Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands’ Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
2
FUNCTIONAL BRANDS INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
| September 30, 2025 | December 31, 2024 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash | $ | 1,005,324 | $ | 211,642 | ||||
| Accounts receivable, net | 89,213 | 303,471 | ||||||
| Inventories, net | 1,690,733 | 1,709,458 | ||||||
| Prepaid expenses and other current assets | 169,070 | 45,112 | ||||||
| Deferred offering costs | 1,256,451 | 588,641 | ||||||
| Total current assets | 4,210,791 | 2,858,324 | ||||||
| Noncurrent assets: | ||||||||
| Property and equipment, net | 42,086 | 49,564 | ||||||
| Right-of-use assets, net | 1,753,581 | 2,000,092 | ||||||
| Intangible assets, net | 1,408,944 | 1,443,541 | ||||||
| Goodwill | 818,139 | 818,139 | ||||||
| Total non-current assets | 4,022,750 | 4,311,336 | ||||||
| Total assets | $ | 8,233,541 | $ | 7,169,660 | ||||
| Liabilities and stockholders’ equity / (deficit) | ||||||||
| Current liabilities: | ||||||||
Accounts payable and accrued liabilities | $ | 2,425,006 | $ | 1,956,165 | ||||
| Line of credit | 21,286 | 32,235 | ||||||
| SBA loan, current | 3,547 | 3,436 | ||||||
| Lease liabilities, current | 364,505 | 291,213 | ||||||
| Other current liabilities | 34,425 | 35,332 | ||||||
| Payable for acquisition, current | 2,227,366 | 2,342,366 | ||||||
| Loans payable (related party), current | 58,886 | 370,703 | ||||||
| Loans payable | 567,497 | 171,500 | ||||||
| Total current liabilities | 5,702,518 | 5,202,950 | ||||||
| Non-current liabilities: | ||||||||
| Lease liabilities, net of current | 1,527,586 | 1,844,819 | ||||||
| SBA loan, net of current | 137,780 | 140,468 | ||||||
| Loan payable (related party), net of current | 260,992 | - | ||||||
| Convertible debenture | - | 100,000 | ||||||
| Total non-current liabilities | 1,926,358 | 2,085,287 | ||||||
| Total liabilities | 7,628,876 | 7,288,237 | ||||||
| Stockholders’ equity / (deficit) | ||||||||
| Series A Preferred stock, par value $0.001, 100,000 shares authorized; 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | - | - | ||||||
| Series B Preferred stock, par value $0.001, 80,000 shares authorized; 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | - | - | ||||||
| Common stock, par value $0.00001, 220,000,000 shares authorized; 7,084,769 and 6,694,880 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 71 | 67 | ||||||
| Additional paid-in capital | 8,359,361 | 7,542,286 | ||||||
| Accumulated deficit | (7,754,767 | ) | (7,660,930 | ) | ||||
| Total stockholders’ equity / (deficit) | 604,665 | (118,577 | ) | |||||
| Total liabilities and stockholders’ equity / (deficit) | $ | 8,233,541 | $ | 7,169,660 | ||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
3
FUNCTIONAL BRANDS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue, net of returns | $ | 1,694,174 | $ | 1,395,913 | $ | 5,116,963 | $ | 4,886,359 | ||||||||
| Cost of goods sold | 715,824 | 632,194 | 2,303,752 | 2,268,986 | ||||||||||||
| Gross profit | 978,350 | 763,719 | 2,813,211 | 2,617,373 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Sales and marketing | 118,876 | 156,497 | 462,545 | 454,714 | ||||||||||||
| General and administrative expenses | 937,762 | 825,993 | 2,616,489 | 2,256,004 | ||||||||||||
| Total operating expenses | 1,056,638 | 982,490 | 3,079,034 | 2,710,718 | ||||||||||||
| Operating income / (loss) | (78,288 | ) | (218,771 | ) | (265,823 | ) | (93,345 | ) | ||||||||
| Interest expense | (155,310 | ) | (69,638 | ) | (321,417 | ) | (189,552 | ) | ||||||||
| Other income – ERTC refund | 491,801 | - | 491,801 | - | ||||||||||||
| Other income | - | - | 112 | - | ||||||||||||
| Interest income | 798 | 328 | 1,490 | 1,291 | ||||||||||||
| Total other income / (expenses) | 337,289 | (69,310 | ) | 171,986 | (188,261 | ) | ||||||||||
| Net income / (loss) | $ | 259,001 | $ | (288,081 | ) | $ | (93,837 | ) | $ | (281,606 | ) | |||||
| Net income (loss) per share of common stock attributable to common stockholders | ||||||||||||||||
| Basic | $ | 0.04 | $ | (0.04 | ) | $ | (0.01 | ) | $ | (0.04 | ) | |||||
| Diluted | $ | 0.04 | $ | (0.04 | ) | $ | (0.01 | ) | $ | (0.04 | ) | |||||
| Weighted average shares used in computing net loss per share of common stock | ||||||||||||||||
| Basic | 7,039,144 | 6,694,493 | 6,953,265 | 6,694,493 | ||||||||||||
| Diluted | 7,197,605 | 6,694,493 | 6,953,265 | 6,694,493 | ||||||||||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
4
FUNCTIONAL BRANDS INC.
CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
| Nine Months Ended September 30, | ||||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (93,837 | ) | $ | (281,606 | ) | ||
| Reconcile net loss to cash provided by operating activities | ||||||||
| Allowance for doubtful accounts receivable | (3,796 | ) | - | |||||
| Allowance for inventory obsolescence | 12,895 | - | ||||||
| Depreciation of property and equipment | 15,990 | 40,576 | ||||||
| Amortization of right-of-use assets | 246,511 | 227,912 | ||||||
| Amortization of intangible assets | 34,597 | 34,597 | ||||||
| Financing expense on warrant issuance | 45,263 | - | ||||||
| Stock-based compensation | 598,856 | - | ||||||
| Issuance of shares for financing expense | 50,630 | - | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 218,054 | (103,316 | ) | |||||
| Inventories | 5,830 | (59,921 | ) | |||||
| Prepaid expenses and other current assets | 1,042 | 1,429 | ||||||
| Accounts payable and accrued liabilities | 591,172 | 331,409 | ||||||
| Other current liabilities | (908 | ) | (31,515 | ) | ||||
| Lease liabilities | (243,941 | ) | (213,743 | ) | ||||
| Net cash provided by (used in) operating activities | 1,478,358 | (54,178 | ) | |||||
| Cash flows from investing activities: | ||||||||
| Purchase of property and equipment | (8,512 | ) | (1,881 | ) | ||||
| Net cash used in investing activities: | (8,512 | ) | (1,881 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Deferred offering costs | (667,810 | ) | (95,625 | ) | ||||
| Proceeds from loans | 195,277 | 280,000 | ||||||
| Payments for payable for acquisition | (115,000 | ) | (200,001 | ) | ||||
| Proceeds from debt facilities | 99,735 | 86,662 | ||||||
| Repayment of loans | (75,106 | ) | (4,492 | ) | ||||
| Line of credit repayment | (110,683 | ) | (132,329 | ) | ||||
| SBA loan repayment | (2,577 | ) | (2,421 | ) | ||||
| Net cash used in financing activities | (676,164 | ) | (68,206 | ) | ||||
| Increase (decrease) in cash | 793,682 | (124,265 | ) | |||||
| Cash beginning of period | 211,642 | 374,435 | ||||||
| Cash, end of period | $ | 1,005,324 | $ | 250,170 | ||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash paid for interest | $ | 241,662 | $ | 187,031 | ||||
| Non-cash investing and financing activities | ||||||||
| Common stock issued for convertible note payable and accrued interest | $ | 122,331 | $ | - | ||||
| Loan payable, related party | $ | 225,000 | $ | - | ||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
5